Home | Contact Us | About Us | News
Specimens | Resources | ACSR member site
Links
Related sites
The East Coast AIDS and Cancer Specimen Resource (EC ACSR) was established by the National Cancer Institute as part of the national AIDS and Cancer Specimen Resource (ACSR) in 1994. The goal of the bank is to collect, preserve, and maintain a comprehensive, confidential, state-of-the-art bank of malignant and other specimens and clinical data from HIV-infected individuals for national research. The specimens for the EC ACSR are maintained within the Department of Pathology at the George Washington University Medical Center (GWUMC).
ACSR Mid-Region Site - Ohio State University administers the Mid-Region of ACSR Program. Affiliates include Emory University, Rush University, University of Texas Southwestern, and Vanderbilt University.
NATIONAL CANCER INSTITUTE - The National Cancer Institute (NCI) is a component of the National Health Institutes and the Federal Government’s primary agency for cancer research and training. The NCI coordinates the National Cancer Program, which conducts and supports research, training, health information dissemination, and other programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation from cancer, and the continuing care of cancer patients and their families.
The NCI Clinical Trials Cooperative Groups have banked tumor specimens from large numbers of uniformly treated cancer patients with a variety of malignancies. Each group has a review process for research proposals. If proposals receive favorable reviews, specimens with clinical, treatment and outcome data can be made available to researchers through collaborative arrangements. These banked specimens are most useful for clinical correlative studies on uniformly treated patient populations. Contact the NCI Specimen Resource Locator website or the NCI Tissue Expediter, (301) 496-7147; e-mail: tissexp@mail.nih.gov.
The NCI Cooperative Breast Cancer Tissue Resource (CBCTR) can provide researchers with access to approximately 9,000 cases of formalin-fixed, paraffin-embedded primary breast cancer tissue, with associated pathology and clinical data. The collection is particularly well-suited for validation studies of diagnostic and prognostic markers. Contact CBCTR's website or Ms. Sherrill Long, Information Management Services, Inc., (301) 984-3445; e-mail: longs@imsweb.com.
The NCI Cooperative Human Tissue Network (CHTN) provides normal, benign, pre-cancerous and cancerous human tissue to the scientific community for basic and developmental studies in many areas of cancer research. Contact the CHTN website or 1-866-GO2-CHTN (1-866-462-2486)
The NCI Specimen Resource Locator is a database that helps researchers locate specimens for research. The database includes resources such as tissue banks and tissue procurement systems with access to normal, benign, pre-cancerous and/or cancerous human tissue covering a wide variety of organ sites. Researchers specify the types of specimens, number of cases, preservation methods and associated data they require. The Locator will search the database and return a list of tissue resources most likely to meet the requirements. When no match is obtained, the researcher is referred to the NCI Tissue Expediter (e-mail: tissexp@mail.nih.gov). The Tissue Expediter is a scientist who helps match researchers with appropriate resources or identify appropriate collaborators when those are necessary.
The Manhattan HIV Brain Bank (MHBB) is a research resource (R24 award) funded by the National Institute of Mental Health. Due to the advanced nature of its cohort, patients with a variety of neoplasms have been enrolled, including those with central nervous system lymphomas. Most current holdings are in the form of fixed, embedded tissues that can be sectioned and assembled into microarrays; frozen tissues and fluids are being collected prospectively. Inventories will be listed through the ACSR.
The NIH AIDS Reagent Program evolved from a small bank of HIV research materials into a unique worldwide resource of state-of-the art reagents for HIV and other pathogens. Many of these reagents are not commercially available. The first Catalog, published in 1988, listed 62 reagents from 20 contributors. The NIH AIDS Reagent Program has grown significantly during the past sixteen years, and it now has over 5,200 reagents for public distribution. Reagents are shipped to scientists all over the world. The value of the NIH AIDS Reagent Program is evident from the diversity of registered users; as of June 2003, scientists from the US and 65 foreign countries registered to receive reagents. During the past year over 14,000 reagents were provided. US scientists obtaining AIDS reagents from the program work primarily in academ-ic settings. There are also users from industry and the Federal Government.
AIDS MALIGNANCY CONSORTIUM (AMC) - The AIDS Malignancy Consortium (AMC) is a NCI-supported clinical trials group, founded in 1995 to support innovative trials for AIDS-associated malignancies. The AMC is committed to enhancing therapeutic options for patients with AIDS-associated malignancies.
AIDS ReSearch Alliance - is a community-based non-profit HIV/AIDS research facility in West Hollywood CA, conducting clinical trials and basic research of promising new therapies for HIV disease. For more information, visit their site at http://www.aidsresearch.org, call 310.358.2423, or contact info@aidsresearch.org.
The Cancer Family Registries (CFRs) include two international registries: the Cancer Family Registry for Breast Cancer Studies (Breast CFR) and the Cancer Family Registry for Colorectal Cancer Studies (Colon CFR). The Breast CFR provides family history information, biological specimens and epidemiologic and clinical data from clinic-based and population-based families at risk for breast and ovarian cancers. The Breast CFR infrastructure is particularly suited to support interdisciplinary and translational breast cancer research. Similarly, the Colon CFR collection includes family history information, epidemiologic and clinical data, and related biological specimens from individuals with colorectal cancer and their families. The colon CFR is a resource for population and clinic-based, translational research in the genetic epidemiology of colorectal cancer. For information on these registries, contact the CFR website or Dr. Daniela Seminara, NCI, (301) 496-9600; e-mail: seminard@mail.nci.nih.gov.
Cell Technology, Inc (CTI) is a woman-owned small business in the Baltimore-Washington Metropolitan area and it is an institutional level member of the International Society for Biological and Environmental Repositories (ISBER). CTI provides repository services for the storage and distribution of Biological materials in a secure and controlled environment. Following facilities are currently available at the CTI Repository: Equipment for the Storage of Biological Materials, Computerized Temperature Monitoring System, Back-up Power Generator, Controlled access to the storage area, and Computerized Inventory Control System.
HIV InSite is a university-based, global Internet resource on HIV/AIDS that incorporates comprehensive, multidisciplinary information on basic science, treatment, prevention, and policy, and is one of the world’s most visited HIV/AIDS Web sites.

HIV InSite is part of the University of California San Francisco’s Center for HIV Information (CHI), whose mission is to advance the prevention and care of HIV infection and related illnesses worldwide through the development, organization, and dissemination of expert knowledge.
The University of California San Francisco-Gladstone Institute of Virology and Immunology Center for AIDS Research (CFAR) seeks to enhance and expand collaborative, multidisciplinary HIV research occurring at the intersections of the basic, clinical and behavioral/epidemiological scientific disciplines.